bf/NASDAQ:ALKS_icon.jpeg

COM:ALKERMES

Alkermes

  • Stock

Last Close

27.91

21/11 19:29

Market Cap

3.89B

Beta: -

Volume Today

479.35K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biopharmaceuticals
  • website

    www.alkermes.com/
  • ipo date

    Jul 16, 1991

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alc...Show More

peer of

competitor of